Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Appointed director

GeneDx Holdings Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Saad Kareem (Chief Transformation Officer) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Sold 85 shares @ $3.5607, valued at $302.7
Exercised 273 restricted stock units @ $0
08/18/2023 4 PFENNIGER RICHARD C JR (Director) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Bought 5,000 shares @ $5.1046, valued at $25.5k
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/08/2023 8-K Investor presentation, Quarterly results
Docs: "GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights",
"One Test: Miss Less. Discover More. GeneDx"
07/27/2023 4 White Karen Ann (Chief People Officer) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Sold 61 shares @ $7.41, valued at $452
Exercised 137 restricted stock units @ $0
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2023 8-K Quarterly results
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2023 4 White Karen Ann (Chief People Officer) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Sold 45 shares @ $5.99, valued at $269.6
Exercised 99 restricted stock units @ $0
07/05/2023 4 Saad Kareem (Chief Transformation Officer) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Sold 83 shares @ $5.99, valued at $497.2
Exercised 273 restricted stock units @ $0
06/09/2023 SC 13G/A Flynn James E reports a 4.9% stake in GeneDX Holdings Corp.
06/06/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/31/2023 4 Ro Isaac (Former CFO) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Sold 2,296 shares @ $1.3187, valued at $3k
Exercised 7,396 restricted stock units @ $0
05/31/2023 4 Assad Shawn (Former CAO) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Sold 1,497 shares @ $1.3187, valued at $2k
Sold 3,166 shares @ $2.17, valued at $6.9k
Exercised 5,139 restricted stock units @ $0
Exercised 10,457 restricted stock units @ $0
05/18/2023 4 Feeley Kevin (CFO) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Sold 1,516 shares @ $6.4985, valued at $9.9k
05/18/2023 4 Stueland Katherine (CEO) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Sold 8,685 shares @ $6.4985, valued at $56.4k
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Investor presentation, Quarterly results
Docs: "GeneDx Reports First Quarter 2023 Financial Results and Business Highlights",
"One Test: Miss Less. Discover More. GeneDx"
05/08/2023 ARS Form ARS - Annual Report to Security Holders:
05/04/2023 4 Clark Daniel Emmett (Former Secretary and GC) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Sold 1,207 shares @ $1.3187, valued at $1.6k
Exercised 4,005 restricted stock units @ $0
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2023 4 Stueland Katherine (CEO) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Exercised 511,364 restricted stock units @ $0
05/02/2023 4 Feeley Kevin (CFO) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Exercised 99,432 restricted stock units @ $0
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/28/2023 4 Saad Kareem (Chief Transformation Officer) has filed a Form 4 on GeneDx Holdings Corp.
Txns: Sold 2,612 shares @ $1.3187, valued at $3.4k
Exercised 9,005 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy